Drug Approval | July 24, 2022
SMS Pharmaceuticals receives approval for Ibuprofen by EDQM
With this, the company can start selling Ibuprofen in the European markets.
With this, the company can start selling Ibuprofen in the European markets.
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China
Manish led SeQuent since 2014 and played a major role in transforming the company
George Svokos joins Avet after serving as a strategic business advisor to numerous global healthcare companies
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
The objective of this Phase 1 study is to determine the safety and tolerability of OLX10212 in patients with advanced AMD at multiple sites in the US.
The over-the-counter market has long been an important segment of Glenmark’s portfolio around the world
This facility will produce higher efficacy products that enjoy greater acceptance and enhanced profit marginsg
ANI’s Clorazepate Dipotassium Tablets are the generic version of the Reference Listed Drug (RLD) Tranxene.
U.S. FDA has issued Form 483 with six observations after an inspection of the company’s formulation manufacturing facility based out of Baddi
Subscribe To Our Newsletter & Stay Updated
